Search research articles
Contact Us
Filters
Showing results (281-290 of 296) with videos related to
Page
of 30
Sort By:
Cancer Cell
|
May 16, 2019
Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair
Jianhui Ma, Jorge A Benitez, Jie Li, et al.
Cancer Cell
|
December 11, 2019
Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair
Jianhui Ma, Jorge A Benitez, Jie Li, et al.
JAMA Oncology
|
October 29, 2020
Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma: A Randomized Clinical Trial
Timothy F Cloughesy, Kevin Petrecca, Tobias Walbert, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 8, 2023
Integrated analysis of single-cell chromatin state and transcriptome identified common vulnerability despite glioblastoma heterogeneity
Ramya Raviram, Anugraha Raman, Sebastian Preissl, et al.
Science Advances
|
March 14, 2018
Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles
Franz L Ricklefs, Quazim Alayo, Harald Krenzlin, et al.
Nature
|
June 4, 2013
The bromodomain protein Brd4 insulates chromatin from DNA damage signalling
Scott R Floyd, Michael E Pacold, Qiuying Huang, et al.
Cancer Research
|
September 4, 2014
Diffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imaging
Nathan S White, Carrie McDonald, Carrie R McDonald, et al.
Genome Research
|
August 20, 2014
RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas
Zhao-Shi Bao, Hui-Min Chen, Ming-Yu Yang, et al.
Science Translational Medicine
|
June 3, 2016
Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma
Timothy F Cloughesy, Joseph Landolfi, Daniel J Hogan, et al.
Genes & Development
|
July 21, 2017
Glioblastoma cellular cross-talk converges on NF-κB to attenuate EGFR inhibitor sensitivity
Ciro Zanca, Genaro R Villa, Jorge A Benitez, et al.
Page
of 30
Search research articles
Search
Showing results (281-290 of 296) with videos related to
Sort By:
Page
of 30
Cancer Cell
|
May 16, 2019
Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair
Jianhui Ma, Jorge A Benitez, Jie Li, et al.
Cancer Cell
|
December 11, 2019
Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair
Jianhui Ma, Jorge A Benitez, Jie Li, et al.
JAMA Oncology
|
October 29, 2020
Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma: A Randomized Clinical Trial
Timothy F Cloughesy, Kevin Petrecca, Tobias Walbert, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 8, 2023
Integrated analysis of single-cell chromatin state and transcriptome identified common vulnerability despite glioblastoma heterogeneity
Ramya Raviram, Anugraha Raman, Sebastian Preissl, et al.
Science Advances
|
March 14, 2018
Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles
Franz L Ricklefs, Quazim Alayo, Harald Krenzlin, et al.
Nature
|
June 4, 2013
The bromodomain protein Brd4 insulates chromatin from DNA damage signalling
Scott R Floyd, Michael E Pacold, Qiuying Huang, et al.
Cancer Research
|
September 4, 2014
Diffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imaging
Nathan S White, Carrie McDonald, Carrie R McDonald, et al.
Genome Research
|
August 20, 2014
RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas
Zhao-Shi Bao, Hui-Min Chen, Ming-Yu Yang, et al.
Science Translational Medicine
|
June 3, 2016
Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma
Timothy F Cloughesy, Joseph Landolfi, Daniel J Hogan, et al.
Genes & Development
|
July 21, 2017
Glioblastoma cellular cross-talk converges on NF-κB to attenuate EGFR inhibitor sensitivity
Ciro Zanca, Genaro R Villa, Jorge A Benitez, et al.
Page
of 30